Prostate News Archive
08-Jun-2011
Prostate cancer drugs may extend survival
prostate cancer is the most common cancer in men, looming as a specter for many as they grow older. So far, this week's headlines about prostate cancer research have been fairly positive, with results from two trials showing promise for extending survival among men with late-stage forms of the cancer. Here?s a look at the latest developments: Safe to skip radiation for prostate cancer?
A review of recent studies comparing different radiation treatments for prostate cancer reveals no clear picture of what works best for the majority of men with the disease. Jury Still Out on Radiation for Early Prostate Cancer
Title: Jury Still Out on Radiation for Early Prostate Cancer Category: Health News Created: 6/6/2011 6:07:00 PM Last Editorial Review: 6/7/2011 Safeway?s 11th Annual Prostate Cancer Fundraiser Kicks Off in Stores
Safeway Inc. launched its month-long prostate Cancer Campaign, a fundraising and awareness campaign, continuing a tradition of raising millions of dollars to find a cure for the most common form of cancer in men.
Back to Prostate News Archive
